Skip to main content
. Author manuscript; available in PMC: 2009 Nov 25.
Published in final edited form as: Eur J Neurol. 2009 Apr;16(4):461–467. doi: 10.1111/j.1468-1331.2008.02398.x

Figure 1.

Figure 1

Increase in per cent from baseline for CBFMCA (■), BFI (○), BFIcorr (□), ICGmax (▲) and rise time (Inline graphic) after infusion of acetazolamide. A significant increase in CBFMCA was found 15 min (48.9 ± 6.6, *** P < 0.001) and 60 min (26.0 ± 6.8, ** P = 0.003) after acetazolamide bolus.